Sacubitril/alisartan
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Sacubitril/alisartan, covering 2025-11-21 to 2025-11-21. Get the full timeline:
Most recent: Clinical Trial Update: Sacubitril/Allisartan for Hypertensive Patients With Overweight or Obesity [Phase 4]